Impressive and credible BOD, will Nasdaq accept, and when and what designations will the FDA B are the only things that will rally and sustain the stock, in my opinion.
I see only one other decline period like this, with 9 days without a green candle.
Well, we had news yesterday and it barely held the gain for the day. Today, drip, drip. We're in a situation now where only blockbuster news will turn the tide. -TheDane
Yesterday's news was more like an update, appreciated, but not something that moves the share price. Some may not have liked it as it puts the Kevetrin trial completion into 2016.